Cargando…

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma

Pancreatic cancer is the third leading cause of cancer-related deaths, characterised by poor survival, marked molecular heterogeneity and high intrinsic and acquired chemoresistance. Only 10–20% of pancreatic cancer patients present with surgically resectable disease and even then, 80% die within 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parkin, Ashleigh, Man, Jennifer, Chou, Angela, Nagrial, Adnan M, Samra, Jaswinder, Gill, Anthony J, Timpson, Paul, Pajic, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313363/ https://www.ncbi.nlm.nih.gov/pubmed/30428574 http://dx.doi.org/10.3390/diseases6040103

Ejemplares similares

Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy
por: Parkin, Ashleigh, et al.
Publicado: (2019)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities
por: Chin, Venessa T., et al.
Publicado: (2015)

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis
por: Byeon, Sooin, et al.
Publicado: (2023)

Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma
por: Tayao, Michael, et al.
Publicado: (2016)

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
por: Adamska, Aleksandra, et al.
Publicado: (2017)

Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
por: Bailey, Peter, et al.
Publicado: (2016)

Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma
por: Roy, Shikha, et al.
Publicado: (2021)

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2018)

MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
por: Castillo, Lesley, et al.
Publicado: (2019)

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
por: Ali, Ahmad, et al.
Publicado: (2022)

The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma
por: Loch, Florian N., et al.
Publicado: (2023)

The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma
por: Xu, Caiming, et al.
Publicado: (2020)

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
por: Topham, James T., et al.
Publicado: (2023)

Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger Patients
por: Lewis, Alison, et al.
Publicado: (2023)

Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
por: Ciernikova, Sona, et al.
Publicado: (2020)

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
por: Yang, Yefan, et al.
Publicado: (2022)

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
por: Ferguson, L. Paige, et al.
Publicado: (2023)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
por: Poh, Ashleigh R., et al.
Publicado: (2021)

Spontaneously evolved progenitor niches escape Yap oncogene addiction in advanced pancreatic ductal adenocarcinomas
por: Murakami, Shigekazu, et al.
Publicado: (2023)

Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
por: Malvi, Parmanand, et al.
Publicado: (2022)

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
por: Ashok Kumar, Prashanth, et al.
Publicado: (2023)

Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
por: Hull, Ashleigh, et al.
Publicado: (2020)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)

Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma
por: Manne, Ashish, et al.
Publicado: (2021)

Subtypes of pancreatic stellate cells and distant metastasis of pancreatic ductal adenocarcinoma
por: Fan, Yuhui, et al.
Publicado: (2020)

Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
por: Ayres Pereira, Marina, et al.
Publicado: (2019)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
por: Pezzilli, Raffaele, et al.
Publicado: (2011)

Clinical and molecular characterization of HER2 amplified-pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2013)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma
por: Jiang, Jiahong, et al.
Publicado: (2021)

The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data
por: Yu, Dong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kp02v7rgl2obrkp37dri1gdpit